Globus Medical (NYSE:GMED) (NYSE: GMED) is a leading designer and developer of innovative spinal implants and related surgical solutions. Founded in 2003 and headquartered in Audubon, Pennsylvania, the company has built its reputation on advancing the standard of care in spine surgery through a broad portfolio of implant systems, biologics, and specialized surgical instruments. Early collaborations with prominent surgeons helped Globus Medical introduce technologies that streamline procedures, reduce operative time, and improve clinical outcomes.
The company’s product offerings encompass a wide range of spinal implant systems, including interbody fusion devices, posterior fixation systems, and minimally invasive surgical platforms. Globus Medical also offers a suite of biologic materials designed to support bone healing and fusion, alongside navigation and robotic-assisted surgery solutions that enable precise implant placement. By integrating its proprietary technology with digital planning and intraoperative guidance tools, the company supports surgeons in delivering consistent, reproducible results for patients suffering from degenerative spinal conditions, trauma, deformity, and other spinal pathologies.
Globus Medical operates globally, serving hospitals, surgical centers, and physician practices across North America, Europe, Asia-Pacific, and Latin America. The company maintains a network of direct sales offices and distributor relationships to ensure timely product availability and responsive clinical support. Ongoing investments in research and development centers in the United States and abroad underscore its commitment to expanding clinical indications, refining surgical workflows, and launching new platforms tailored to regional market needs.
Under the leadership of founder and CEO David Demski, Globus Medical emphasizes a collaborative culture that brings together engineers, surgeons, and healthcare professionals. The executive team’s deep expertise in biomedical engineering, regulatory affairs, and global operations has guided the company’s growth from a start-up to a publicly traded medical device firm. With a focus on innovation, quality manufacturing, and evidence-based performance, Globus Medical continues to pursue strategic partnerships and clinical studies aimed at transforming spine care worldwide.
